-
NOTICE OF FINAL RULEMAKING
The Director of Health, pursuant to the authority set forth in Section 2(a) of the Preventive Health Services Amendments Act of 1985 (“Act”), effective February 21, 1986 (D.C. Law 6-83; D.C. Official Code § 7-301 (2012 Repl.)), and Mayor’s Order 98-141, dated August 20, 1998, hereby gives notice of the adoption of the following amendments to Chapter B2 (Communicable and Reportable Diseases) of Subtitle B (Public Health and Medicine) of Title 22 (Health) of the District of Columbia Municipal Regulations (DCMR).
The rules amend Sections 215, 216, and 299 of Title 22-B to update procedures for reporting cancer.
A Notice of Proposed Rulemaking was published March 28, 2014, at 61 DCR 2689. No comments were received in response to the Notice of Proposed Rulemaking, and no changes have been made since publication of the notice. The Director took final rulemaking action on May 5, 2014. The rules will become effective upon publication of this notice in the D.C. Register.
Chapter 2 of Subtitle 22-B (Public Health and Medicine) is amended as follows:
Subsection 215.1 is amended to read as follows:
215.1 Each health care provider and health care facility shall report benign tumors of the brain and central nervous system and all malignant cancers as follows:
(a) Each health care provider and health care facility shall report within six (6) months of diagnosis or first contact, any patient diagnosed with or treated for benign tumors of the brain or central nervous system or any malignant cancers, or for whom cancer treatment planning was performed but the patient opted for no treatment.
(b) Each health care provider and health care facility shall report within six (6) months of diagnosis or first contact, any patient diagnosed with or treated for benign tumors of the brain or central nervous system or any malignant cancers, or who expired with cancer as a cause of death; and
(c) Each health care provider and health care facility shall make available to the Director or an agent of the Director all information necessary to verify the information in any report submitted pursuant to this section.
Subsection 215.4 is amended to read as follows:
215.4 Each report required by Subsection 215.1 shall be submitted electronically by a secured form of transmission approved by the North American Association of Central Cancer Registries (NAACCR) to the DC Central Cancer Registry within the Department.
Subsection 216.1 is amended to read as follows:
216.1 A District of Columbia Central Cancer Registrar or other person designated by the Director is authorized to visit any health care facility or health care provider to review and duplicate reports required by this chapter or records that contain information required to be submitted pursuant to this chapter to ensure the completeness and accuracy of the information.
Subsection 299.1 is amended by striking the definition for “District of Columbia Central Registrar”.
.
